Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients

April 14, 2016 updated by: Ferran Barbe, Sociedad Española de Neumología y Cirugía Torácica
The purpose of this study is to compare the effectiveness of telemonitoring versus standard follow-up on CPAP treatment compliance in Obstructive Sleep Apnea Syndrome (OSAS).

Study Overview

Status

Completed

Detailed Description

Obstructive Sleep Apnea (OSA) is defined by the presence of repetitive episodes of upper airways collapse during sleep, leading to nocturnal hypoxemia, sleep fragmentation and daytime sleepiness. When untreated, OSA is a risk factor for arterial hypertension , cardiovascular and cerebrovascular diseases, road accidents and a worse quality of life. The application of a continuous positive airways pressure (CPAP) represents the first line therapy in patients with moderate to severe OSA. CPAP treatment improves daytime sleepiness and oxygen saturation , reduces cardiovascular risk, ameliorates neurobehavioral performance, improves quality of life and reduces road accidents. Despite its demonstrated efficacy, CPAP effectiveness is significantly limited by poor adherence. A closer follow up could improve CPAP adherence but it would take up more work and additional costs for sleep units.

So on that account, the investigators propose a study to demonstrate that automatic home treatment monitoring of patients with OSA is a cost-effectiveness alternative approach to patient's management. Moreover, the investigators believe that telemonitoring could improve CPAP compliance and patient's satisfaction and reduce follow-up costs.

Methods:

Prospective and randomized study during three months. Patients diagnosed as OSA in St. Maria's Hospital (Sleep Unit) and requiring CPAP treatment, will be randomized into two groups differing in CPAP compliance monitoring and management .

Group 1 Standard care Patients will be fitted with a mask and given a CPAP and instructed on how to use the device. Patients will follow the standard treatment management. All patients will be visited at 1 month at sleep unit. Patients will be checked about progress and adherence to therapy and any problems with their machine. Information will be downloaded from their machines (CPAP adherence, applied CPAP pressure, mask leak, and residual respiratory events…).

Group 2 Telemonitoring Patients will be fitted with a mask and given a CPAP. Each CPAP device will be provided with a modem sending daily compliance information (CPAP adherence, CPAP pressure, mask leak, and residual respiratory events) to a web database.

Patients of both 2 groups will be finally visited at 3 months at sleep unit.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lleida, Spain, 25198
        • Hospital Arnau de Vilanova-Santa Maria

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and Women over 18 years old
  • Diagnosed as OSA and requiring CPAP treatment
  • Written informed consent form signed.

Exclusion Criteria:

  • Patients with impaired lung function (overlap syndrome, obesity hypoventilation syndrome, and restrictive disorders)
  • Severe heart failure
  • Severe chronic pathology associated
  • Psychiatric disorder
  • Periodic leg movements
  • Pregnancy
  • Other dyssomnias or parasomnias
  • Patients already treated with CPAP

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard follow up-Sleep Unit
Patients diagnosed as OSA, treated with CPAP and followed up in sleep unit
Standard management according to Spanish Respiratory Society guidelines in Sleep Unit.
Experimental: Telemonitoring
Patients diagnosed as OSA and treated with CPAP in sleep unit, followed up by telemonitoring system
Follow up by telemonitoring system during 3 months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CPAP adherence at 3 months
Time Frame: 3 months
Number of hours of use per day of CPAP according to the internal clock of the CPAP device
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' satisfaction at 3 months
Time Frame: 3 months
Patients will be asked to grade their satisfaction with the follow up care provided by telemonitoring /sleep unit using a questionnaire and a visual analogue scale.
3 months
Cost effectiveness at 3 months
Time Frame: 3 months
Costs in each group (CPAP carrying charge, number of visits and calls, number of hospital admissions) will be compared.
3 months
Change from baseline in quality of life at 3 months
Time Frame: 3 months
EuroQOL health questionnaire and visual analogue scale will be used.
3 months
Fast detection of the non-adherent patient with telemonitoring
Time Frame: 3 months
We assume that telemonitoring could quickly detect non- adherent patients.
3 months
Change in blood pressure at 3 months
Time Frame: 3 months
3 months
Change in body mass index at 3 months
Time Frame: 3 months
3 months
Abandons at 3 months
Time Frame: 3 months
Number of patients lost at follow up at 3 months of CPAP therapy.
3 months
Adverse events at 3 months
Time Frame: 3 months
3 months
Change from baseline in snoring at 3 months
Time Frame: 3 months
Patients will be asked about the persistence of snoring
3 months
Change from baseline in witnessed apneas at 3 months
Time Frame: 3 months
Patients will be asked about the persistence of witnessed apneas
3 months
Change from baseline in nocturia at 3 months
Time Frame: 3 months
Patients will be asked about the presence of nocturia.
3 months
Change from baseline in daytime sleepiness at 3 months
Time Frame: 3 months
Epworth sleepiness scale will be used.
3 months
Changes in nocturnal gasping at 3 months
Time Frame: 3 months
Patients will be asked about the persistence of nocturnal gasping
3 months
Changes in sleep fragmentation at 3 months
Time Frame: 3 months
Patients will be asked about the persistence of sleep fragmentation/maintenance insomnia
3 months
Presence of symptoms of restlees leg syndrome at 3 months
Time Frame: 3 months
Patients will be asked about the presence of symptoms of restless leg syndrome
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

July 30, 2015

First Submitted That Met QC Criteria

August 4, 2015

First Posted (Estimate)

August 7, 2015

Study Record Updates

Last Update Posted (Estimate)

April 15, 2016

Last Update Submitted That Met QC Criteria

April 14, 2016

Last Verified

August 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea Syndrome

Clinical Trials on Standard follow-up

Subscribe